Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UHE-101 Cream 1% in Facial Acne Vulgaris
NCT03307577Phase 2Completed
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of UHE-101 in acne vulgaris. Started Oct 2017; status: completed.
02
Drugs
UHE-101
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03307577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307577.